Each filer's latest filing for 98420X103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
| Vanguard Group Inc 13G/A | 4.8% |
1/31/2025
Event 12/31/2024
|
||
| Orbimed Advisors LLC 13G/A | 1.7% |
8/14/2025
Event 6/30/2025
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 3.23 M | $9.38M |
| 2026 Q2 | 1 | 3.23 M | $15.1M |
| 2026 Q1 | 2 | 3.47 M | $14.3M |
| 2025 Q4 | 3 | 3.51 M | $14.0M |
| 2025 Q3 | 2 | 2.51 M | $8.57M |
| 2025 Q2 | 2 | 653 k | $1.24M |
| 2025 Q1 | 95 | 98.5 M | $23.5M |
| 2024 Q4 | 92 | 99.8 M | $73.2M |
| 2024 Q3 | 101 | 101 M | $67.5M |
| 2024 Q2 | 103 | 102 M | $59.1M |
| 2024 Q1 | 101 | 103 M | $144M |
| 2023 Q4 | 96 | 97.3 M | $81.6M |
| 2023 Q3 | 92 | 112 M | $123M |
| 2023 Q2 | 100 | 113 M | $219M |
| 2023 Q1 | 61 | 61.5 M | $53.6M |
| 2022 Q4 | 56 | 60.6 M | $60.2M |
| 2022 Q3 | 61 | 39.1 M | $66.9M |
| 2022 Q2 | 52 | 16.1 M | $15.5M |
| 2022 Q1 | 59 | 16.3 M | $28.7M |
| 2021 Q4 | 54 | 17.6 M | $40.2M |
| 2021 Q3 | 53 | 16.2 M | $85.7M |
| 2021 Q2 | 65 | 16.6 M | $108M |
| 2021 Q1 | 63 | 16.1 M | $139M |
| 2020 Q4 | 55 | 10.5 M | $67.4M |
| 2020 Q3 | 54 | 10.2 M | $69.3M |
| 2020 Q2 | 58 | 11.0 M | $102M |
| 2020 Q1 | 51 | 11.3 M | $113M |
| 2019 Q4 | 55 | 11.0 M | $118M |
| 2019 Q3 | 51 | 7.74 M | $98.4M |
| 2019 Q2 | 45 | 7.61 M | $114M |
| 2019 Q1 | 31 | 1.79 M | $31.1M |